Injections have higher bioavailability compared to oral supplements, ensuring more efficient absorption and utilization by the body
Important precautions and safety considerations include: Personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2 (precaution per UK SmPC) Severe gastrointestinal disease History of pancreatitis (requires careful assessment) Diabetic retinopathy requiring close monitoring Risk of gallbladder disease (seek care for persistent upper abdominal pain, fever, jaundice) Dehydration and possible kidney injury with severe gastrointestinal symptoms (maintain hydration) Small mean heart rate increase noted in trials (consider monitoring in patients with cardiovascular disease) Reduced exposure to oral contraceptives (use barrier contraception for 4 weeks after initiation and dose increases) Avoid during pregnancy and breastfeeding unless clearly necessary When to seek urgent medical attention: Severe, persistent abdominal pain (potential pancreatitis) Signs of allergic reaction (rash, difficulty breathing, facial swelling) Persistent vomiting leading to dehydration Symptoms of hypoglycaemia if taking insulin or sulfonylureas concurrently Blood pressure 180/120 mmHg or if chest pain, severe breathlessness, neurological symptoms, or acute confusion develop Regular follow-up with healthcare professionals, typically every 36 months, allows for assessment of treatment response, adverse effects, and necessary adjustments to the overall treatment plan
GLP-1 Friendly Meal Plan: What to Eat for Weight Loss, Energy, and Blood Sugar Control / With the rise in popularity of GLP-1 medications like Ozempic, Wegovy, and Mounjaro, more people are discovering their powerful benefits for weight loss and blood sugar management
The MTHFR 677TT are hyper methylated
W.RaddingW
Its not the Ozempic that did that
.webp)
